Alector, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALEC Nasdaq 2834 www.alector.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alector, Inc.

Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates - May 7th, 2026 5:05 pm
Alector Reports First Quarter 2026 Financial Results and Provides Business Update - May 7th, 2026 2:05 pm
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know - May 7th, 2026 8:00 am
Alkermes (ALKS) Reports Q1 Loss, Beats Revenue Estimates - May 5th, 2026 6:25 am
GSK Juggles Alzheimer’s Setback And Leadership Shift With Product Progress - May 2nd, 2026 7:19 pm
How The Alector (ALEC) Narrative Is Shifting Toward BBB Shuttle Programs And Execution Risk - Apr 30th, 2026 6:08 am
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis - Apr 29th, 2026 2:05 pm
Discovering Middle East's Undiscovered Gems This April 2026 - Apr 27th, 2026 9:33 pm
Undiscovered Gems in the Middle East for March 2026 - Mar 26th, 2026 2:33 am
Why The Narrative Around Alector (ALEC) Is Shifting With Its BBB Shuttle Focus - Mar 20th, 2026 5:04 pm
Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles - Mar 10th, 2026 8:09 am
Alector (ALEC)'s Technical Outlook is Bright After Key Golden Cross - Mar 10th, 2026 7:55 am
How The Alector (ALEC) Story Is Shifting As Analyst Targets And Sector Views Evolve - Mar 4th, 2026 4:08 am
Alector Showcases ABC Brain-Delivery Platform, AL137 and AL050 Updates at TD Cowen Conference - Mar 3rd, 2026 7:45 pm
Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates - Feb 25th, 2026 5:25 pm
Alector: Q4 Earnings Snapshot - Feb 25th, 2026 2:19 pm
Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Feb 25th, 2026 2:05 pm
Alector to Participate in the TD Cowen 46th Annual Health Care Conference - Feb 24th, 2026 6:00 am
What The New Sector Driven Price Target Means For Alector's Story And Valuation - Feb 17th, 2026 7:10 pm
VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Lags Revenue Estimates - Feb 12th, 2026 3:45 pm